Lobbying client

NEURELIS, INC.

Biopharmaceutical company specializing in treatments for neurological conditions.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
11
Filed by
2
Reported in-house
—
Reported by firms
$130,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2024 to 2026

Filings

11 filings, newest first.
Filing Filed by Amount
Registration
4th Quarter 2024
ARNOLD & PORTER KAYE SCHOLER LLP — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ARNOLD & PORTER KAYE SCHOLER LLP 8 $90,000
FEROX STRATEGIES 1 $40,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 7
Medicare/Medicaid MMM 2

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 7383 119th 3
S. 1214 119th 3
S. 932 119th 2
H.R. 1262 119th 2
H.R. 7383 118th 1
S. 1214 118th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.